A recent notice from the US Department of Health and Human Services and the Food and Drug Administration that could lead to the exemption of 84 types of medical devices from premarket review falls under the umbrella of a Biden administration regulatory freeze, an attorney told Medtech Insight.
In their joint 14 January notice, the HHS and the FDA suspended premarket notification requirements for seven low-risk class I devices – all of them gloves. The regulators said...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?